| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |